Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi: adialpharma.com (ADIL)

While Adial Pharmaceuticals (ADIL) undergoes complex clinical trials for its personalized agent AD04, the company is successfully implementing ESG standards and biosafety. The EBITDA history on this GURU.Markets chart shows that 0.00 captures a new operating profit level. This is driven by automated biochemical tests, which accelerate drug verification through the robotization of analysis.

ADIL Bathi operasional EBITDA Adial Pharmaceuticals Inc. (23.11.2025 - 29.10.2026)

Adial Pharmaceuticals, Inc. (ADIL) - rincian metrik lan laporan keuangan

- rega pasar lan target rega analis:

Rega saham Adial Pharmaceuticals Inc.|ADIL - Bagan rega target

- indikator kapitalisasi bursa perusahaan:

Nilai pasar Adial Pharmaceuticals|ADIL - Nilai Total Perusahaan

- informasi kapitalisasi buku:

Nilai Akuntansi saben Saham Adial Pharmaceuticals|ADIL - Kapitalisasi Buku|Rasio Kapitalisasi Pasar marang Nilai Buku adialpharma.com|ADIL - Total Aset Perusahaan

- data tingkat utang lan likuiditas finansial:

Rasio Utang marang Ekuitas Adial Pharmaceuticals|ADIL - Utang jangka dawa marang modal|Koefisien utang jangka cendhak marang modal Adial Pharmaceuticals Inc.|ADIL - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Adial Pharmaceuticals|ADIL - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Adial Pharmaceuticals|Rasio jangkoan perantara adialpharma.com

- data bathi lan kelipatan valuasi:

ADIL - Bathi resik perusahaan|Bathi forward Adial Pharmaceuticals|ADIL - Pangali P/E|Pangali mangsa ngarep rega marang bathi Adial Pharmaceuticals Inc.|ADIL - Pangali PEG|Pangali EV/EBITDA Adial Pharmaceuticals|ADIL - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi saben saham sajroning taun lumaku Adial Pharmaceuticals|ADIL - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan adialpharma.com|ADIL - Wutah bathi ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Adial Pharmaceuticals

Ringkesan analitik perusahaan:ADIL (Adial Pharmaceuticals)

The high scalability of Adial Pharmaceuticals (ADIL) enables the generation of significant cash flow against fixed production costs for its patented drugs. This metric captures the daily balance of operating profit before depreciation and interest, reflecting the real-time balance of supply and demand, which allows for an assessment of current business efficiency through an EBITDA snapshot.

Pesaing Adial Pharmaceuticals (ADIL)